|
What’s ahead for Russia’s generic and innovative drugs market?
Report reveals market value, forecasts for development 2014-2019.
How do physicians view the expanding selection of generics and innovative treatments available in Russia? Which company manufactures the largest quantity of generic drugs and innovative treatments for this market? How is pricing determined in this market and how does the Russian reimbursement system work? How long does a patent remain valid in this market? What is the current value of this market and each of its segments? How will these numbers change by 2019?
Readers can find answers to these common market questions, plus many others, in Generic and innovative drugs market in Russia, development forecasts for 2014-2019. This publication combines a broad range of useful data with the analyses of experienced analysts to produce a comprehensive collection of information that will benefit every professional at work in the marketplace.
The report determines the market share of generic and innovative drugs in Russia’s overall pharmaceutical sector. It offers fresh data on market value, overall and for each segment, including historical data captured in recent years.
This document supplies complete coverage of the pricing, markup and reimbursement rules and procedures utilised in the Russian pharmaceutical market for these types of medicines. It includes proposed and planned changes to rules in accordance with the Russian Pharma 2020, a government program that aims to expand domestic manufacturing of generic and innovative drugs and regulate the activity of international producers more closely.
Patent procedures and data exclusivity issues are also explored at length in the pages of this report, which highlights the unique issues that face developers of new generic and innovative treatment options. Additional vital market topics include: top-selling generic and innovative drugs on the Russian market and continued efforts to eliminate the flow of counterfeit products into the market.
Profiles of top manufacturers of generic and innovative drugs for the Russian market are also included in the publication. They provide size, value and location and contact data, as well as plans for new ventures and new product launches.
This publication is essential to planning and operations executives at companies that manufacture generic and innovative drugs for the Russian market. It is a must read for those who need to assess the market in advance of launching a new business or expanding a current one. It is also extremely useful to banking and investment professionals, government employees and business consultants, as well as research specialists and analysts.
Generic and innovative drugs market in Russia, Development forecasts for 2014-2019 is useful when assembling or revising a product portfolio, successfully launching a new business on the market and assessing its potential for investment and growth. It is an irreplaceable resource when studying the changing regulatory situation in this market – it keeps businesspeople updated and knowledgeable of all regulations (and impending changes) that apply to the manufacture and marketing of these new and sought after medicines.
Discover what the future holds for the generic and innovative drugs market in Russia - order your copy of this ‘must have’ publication today!
|
현재위치 : 
